Your browser doesn't support javascript.
loading
Semaphorins as Potential Immune Therapeutic Targets for Cancer.
Jiang, Jun; Zhang, Fang; Wan, Yi; Fang, Ke; Yan, Ze-Dong; Ren, Xin-Ling; Zhang, Rui.
Afiliação
  • Jiang J; Department of Health Service, Fourth Military Medical University, Xi'an, China.
  • Zhang F; State Key Laboratory of Cancer Biology, Department of Immunology, Fourth Military Medical University, Xi'an, China.
  • Wan Y; Department of Respiratory Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
  • Fang K; Department of Health Service, Fourth Military Medical University, Xi'an, China.
  • Yan ZD; Department of Health Service, Fourth Military Medical University, Xi'an, China.
  • Ren XL; Department of Biomedical Engineering, Fourth Military Medical University, Xi'an, China.
  • Zhang R; Department of Respiratory Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Front Oncol ; 12: 793805, 2022.
Article em En | MEDLINE | ID: mdl-35155237
ABSTRACT
Semaphorins are a large class of secreted or membrane-bound molecules. It has been reported that semaphorins play important roles in regulating several hallmarks of cancer, including angiogenesis, metastasis, and immune evasion. Semaphorins and their receptors are widely expressed on tumor cells and immune cells. However, the biological role of semaphorins in tumor immune microenvironment is intricate. The dysregulation of semaphorins influences the recruitment and infiltration of immune cells, leading to abnormal anti-tumor effect. Although the underlying mechanisms of semaphorins on regulating tumor-infiltrating immune cell activation and functions are not fully understood, semaphorins can notably be promising immunotherapy targets for cancer.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article